13 Apr 2022
Dr Liddicoat to participate in Nordic Intellectual Property Review webinar on patent repurposing for rare diseases
On Monday 25 April 2022, Dr John Liddicoat (LML Senior Research Associate) will participate in Patent Repositioning for rare diseases – too much, too little or just right?, a webinar organised by the Nordic Intellectual Property Review.Ensuring access to treatments for underserved populations is a key priority in both the European Medicines Agency’…
23 Mar 2022
American Journal of Public Health publishes article co-authored by Prof. Kathy Liddell on governing global antimicrobial resistance
The American Journal of Public Health has published an article co-authored by Prof. Kathy Liddell (Director of LML) on governing global antimicrobial resistance.Antimicrobial resistance (AMR) is among the most urgent global health challenges of our time. AMR can develop with each use of an antimicrobial, regardless of the setting. Some microbes hav…
27 Jan 2022
Nature Biotechnology accepts paper from LML on European Patent Protection for Medical Uses of Known Products and Drug Repurposing
Nature Biotechnology has accepted an eighth article from LML’s empirical-based IP research group.Drug repurposing is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indications. Finding new therapeutic uses for existing medicines holds significant potential, since it is of…
19 Jan 2022
Dr Stephanie Palmer and Dr Stevie Martin appointed as General Editors of European Human Rights Law Review
Two members of LML, Dr Stephanie Palmer and Dr Stevie Martin have been appointed (alongside Dr Kirsty Hughes) as the General Editors of the European Human Rights Law Review (EHRLR).The EHRLR is the leading human rights law journal providing unrivalled, cutting-edge coverage of key issues in human rights law. It is at the forefront of serious discus…
14 Jan 2022
Medical Law Review publishes article by LML team on negligent standards of care in diagnosis
Diagnosis lies at the heart of the medical encounter, yet it has received much less attention in legal literature than treatment. Though it is widely assumed that negligent diagnosis claims should be governed by the Bolam test, the article ‘Differentiating Negligent Standards of Care in Diagnosis’ argues that this is not always the case.Co-authore…
13 Jan 2022
Medical Law Review publishes LML article on negligent standards of care in diagnosis
Diagnosis lies at the heart of the medical encounter, yet it has received much less attention in legal literature than treatment. Though it is widely assumed that negligent diagnosis claims should be governed by the Bolam test, ‘Differentiating Negligent Standards of Care in Diagnosis’ argues that this is not always the case.Co-authored by Prof. Ka…
10 Nov 2021
Nature Biotechnology publishes LML paper on new medical use patents
‘Mapping the European Patent Landscape for Medical Uses of Known Products’, co-authored by Prof. Mateo Aboy, Prof. Kathy Liddell, Dr John Liddicoat, Dr Cristina Crespo, and Matt Jordan, uses EPO data to examine the European patent landscape of first and further medical uses of known products. Specifically, the paper addresses three research questio…
4 Nov 2021
Stevie Martin awarded Yorke Prize
Dr Stevie Martin has been awarded the Yorke Prize for her doctoral thesis entitled 'Assisted Suicide and the European Convention on Human Rights', which was published by Routledge earlier this year. The Yorke Prize was endowed in 1873 by Edmund Yorke, Scholar and Fellow of St Catharine’s College, and it is awarded annually by the Faculty of Law at …
6 Sep 2021
Tickets still available for CeBIL Symposium 2021 - Orphan Drug Innovation: Needs and Priorities
Tickets are still available to attend the CeBIL Annual Symposium 2021 - Orphan Drug Innovation: Needs and Priorities.Rare diseases affect approximately 25-30 million people in Europe, including millions of children. However, since each disease affects less than one person in every 2,000, the pharmaceutical industry has traditionally been reluctant …
2 Sep 2021
Nature Biotechnology accepts paper from LML on new medical use patents
Nature Biotechnology has accepted a seventh article from LML’s empirical-based IP research group.Most countries active in pharmaceutical innovation offer patent protection and market exclusivity for new medical uses of known products. However, the question of whether such policies offer sustainable business models is an active debate within the fie…
20 Jul 2021
LML published in International Review of Intellectual Property and Competition Law
LML is pleased to announce that International Review of Intellectual Property and Competition Law has published 'Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the ‘‘+1’’ Regulatory Exclusivity' by John Liddicoat, Kathy Liddell, Mateo Aboy, and Jakob Wested. This paper forms part of LML's contribution to the Co…
4 Jul 2021
Registration open for Orphan Drug Symposium
LML is delighted to announce that registration has opened for the CeBIL Annual Symposium 2021 - Orphan Drug Innovation: Needs and Priorities.Rare diseases affect approximately 25-30 million people in Europe, including millions of children. However, since each disease affects less than one person in every 2,000, the pharmaceutical industry has tradi…
23 Jun 2021
LML publishes article on cross-border transfers of health data in Journal of Law and the Biosciences
LML is pleased to announce that the Journal of Law and the Biosciences has published ‘Standard contractual clauses for cross-border transfers of health data after Schrems II’, authored by Laura Bradford, Mateo Aboy, and Kathy Liddell.Standard contractual clauses (SCCs) have long been considered the most accessible method to transfer personal data l…
28 Apr 2021
Dr Stevie Martin’s PhD Thesis Published by Routledge
LML is delighted to announce that Dr Stevie Martin’s PhD thesis, ‘Assisted Suicide and the European Convention on Human Rights’, has been published by Routledge.Locating assisted suicide within the broader medical end-of-life context and drawing on the empirical data available from the increasing number of permissive jurisdictions, this book provid…
27 Apr 2021
Dr John Liddicoat participates in Seminar on Drug Repurposing
On 27 April 2021, Dr John Liddicoat (LML Senior Research Associate) participated in ‘Drug Repurposing in the EU – an Innovation Failure’. At this event, part of the Finnish IPR University Center’s Dialogue of Experts series, Dr Liddicoat elaborated on the findings of two forthcoming papers: ‘Has the EU Incentive for Drug Repositioning been Effectiv…
